» Articles » PMID: 29626094

The Substrate-binding Cap of the UDP-diacylglucosamine Pyrophosphatase LpxH is Highly Flexible, Enabling Facile Substrate Binding and Product Release

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2018 Apr 8
PMID 29626094
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Gram-negative bacteria are surrounded by a secondary membrane of which the outer leaflet is composed of the glycolipid lipopolysaccharide (LPS), which guards against hydrophobic toxins, including many antibiotics. Therefore, LPS synthesis in bacteria is an attractive target for antibiotic development. LpxH is a pyrophosphatase involved in LPS synthesis, and previous structures revealed that LpxH has a helical cap that binds its lipid substrates. Here, crystallography and hydrogen-deuterium exchange MS provided evidence for a highly flexible substrate-binding cap in LpxH. Furthermore, molecular dynamics simulations disclosed how the helices of the cap may open to allow substrate entry. The predicted opening mechanism was supported by activity assays of LpxH variants. Finally, we confirmed biochemically that LpxH is inhibited by a previously identified antibacterial compound, determined the potency of this inhibitor, and modeled its binding mode in the LpxH active site. In summary, our work provides evidence that the substrate-binding cap of LpxH is highly dynamic, thus allowing for facile substrate binding and product release between the capping helices. Our results also pave the way for the rational design of more potent LpxH inhibitors.

Citing Articles

Design and Evaluation of Pyridinyl Sulfonyl Piperazine LpxH Inhibitors with Potent Antibiotic Activity Against Enterobacterales.

Ennis A, Cochrane C, Dome P, Jeong P, Yu J, Lee H JACS Au. 2024; 4(11):4383-4393.

PMID: 39610720 PMC: 11600146. DOI: 10.1021/jacsau.4c00731.


Antibiotic class with potent in vivo activity targeting lipopolysaccharide synthesis in Gram-negative bacteria.

Huseby D, Cao S, Zamaratski E, Sooriyaarachchi S, Ahmad S, Bergfors T Proc Natl Acad Sci U S A. 2024; 121(15):e2317274121.

PMID: 38579010 PMC: 11009625. DOI: 10.1073/pnas.2317274121.


Lipid-Centric Approaches in Combating Infectious Diseases: Antibacterials, Antifungals and Antivirals with Lipid-Associated Mechanisms of Action.

Ostroumova O, Efimova S Antibiotics (Basel). 2023; 12(12).

PMID: 38136750 PMC: 10741038. DOI: 10.3390/antibiotics12121716.


Unrealized targets in the discovery of antibiotics for Gram-negative bacterial infections.

Theuretzbacher U, Blasco B, Duffey M, Piddock L Nat Rev Drug Discov. 2023; 22(12):957-975.

PMID: 37833553 DOI: 10.1038/s41573-023-00791-6.


Development of LpxH Inhibitors Chelating the Active Site Dimanganese Metal Cluster of LpxH.

Kwak S, Cochrane C, Cho J, Dome P, Ennis A, Kim J ChemMedChem. 2023; 18(11):e202300023.

PMID: 37014664 PMC: 10239344. DOI: 10.1002/cmdc.202300023.


References
1.
Wang J, Wolf R, Caldwell J, Kollman P, Case D . Development and testing of a general amber force field. J Comput Chem. 2004; 25(9):1157-74. DOI: 10.1002/jcc.20035. View

2.
Sanner M . Python: a programming language for software integration and development. J Mol Graph Model. 2000; 17(1):57-61. View

3.
Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

4.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

5.
Roe D, Cheatham 3rd T . PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. J Chem Theory Comput. 2015; 9(7):3084-95. DOI: 10.1021/ct400341p. View